Projects funded by the NCN
Gaining control on XBP1s signaling as a starting point for novel cancer therapies
2022/47/B/NZ7/00051
Keywords:
IRE1 RIDD Target mask miRNA UPR XBP1s
Descriptors:
- NZ3_1: Cell biology
- NZ1_1: Molecular biology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Wrocławski, Wydział Biotechnologii
woj. dolnośląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: OPUS 24 - announced on 2022-07-15
Amount awarded: 2 143 540 PLN
Project start date (Y-m-d): 2023-07-11
Project end date (Y-m-d): 2027-07-10
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.